The global rheumatoid arthritis drugs market is anticipated to grow at a significant CAGR 2% during the forecast period (2022-2028). The increasing prevalence of arthritis and other joint problems creating demand for its treatment which in turn driving the global rheumatoid arthritis drug market. In addition, advances in biosimilar and novel biologics are expected to […]
